BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12407728)

  • 1. Quantitative analysis of heparanase messenger RNA expression in hepatocellular carcinoma.
    Ikeguchi M; Ueta T; Yamane Y; Hirooka Y; Kaibara N
    J Surg Oncol; 2002 Nov; 81(3):148-54; disscusion 154. PubMed ID: 12407728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of heparanase mRNA and its clinical significance in primary hepatocellular carcinoma].
    Zhang YL; Fu ZR; Ding GS; Fu H; Wang YH; Wang Q
    Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):359-61. PubMed ID: 12921566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma].
    Liu Y; Chen X; Peng S; Fang H; Wu Y; Peng C; Shi L; Bai M; Xu B; Wang J; Deng G
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1553-6. PubMed ID: 12609066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma.
    Ikeguchi M; Hirooka Y; Kaibara N
    Cancer; 2002 Nov; 95(9):1938-45. PubMed ID: 12404288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expression of Heparanase mRNA and its clinical significance in Hepatocellular carcinoma.
    Wang Q; Shen Y; Wang P; Li X
    J Cancer Res Ther; 2013; 9(2):250-2. PubMed ID: 23771368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The gene expression level of transforming growth factor-beta (TGF-beta) as a biological prognostic marker of hepatocellular carcinoma.
    Ikeguchi M; Iwamoto A; Taniguchi K; Katano K; Hirooka Y
    J Exp Clin Cancer Res; 2005 Sep; 24(3):415-21. PubMed ID: 16270528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinicopathological significance of heparanase and basic fibroblast growth factor expressions in hepatocellular carcinoma.
    El-Assal ON; Yamanoi A; Ono T; Kohno H; Nagasue N
    Clin Cancer Res; 2001 May; 7(5):1299-305. PubMed ID: 11350898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of RhoA in progression of human hepatocellular carcinoma.
    Wang D; Dou K; Xiang H; Song Z; Zhao Q; Chen Y; Li Y
    J Gastroenterol Hepatol; 2007 Nov; 22(11):1916-20. PubMed ID: 17914970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Expression of vascular endothelial growth factor (VEGF) family members and prognosis after hepatic resection in HBV-related hepatocellular carcinoma].
    Moon JI; Kim JM; Jung GO; Chun JM; Choi GS; Park JB; Kwon CH; Kim SJ; Jo JW
    Korean J Hepatol; 2008 Jun; 14(2):185-96. PubMed ID: 18617766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of peritoneal micrometastasis by reverse transcriptase-polymerase chain reaction for heparanase mRNA and cytology in peritoneal wash samples.
    Wang Z; Zhang X; Xu H; Zhou X; Jiang L; Lu C
    J Surg Oncol; 2005 May; 90(2):59-65. PubMed ID: 15844185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene and protein expression of RCAS1 in hepatocellular carcinoma.
    Ikeguchi M; Hirooka Y; Kaibara N
    Anticancer Res; 2003; 23(6D):4967-71. PubMed ID: 14981953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of survivin mRNA associates with apoptosis, proliferation and histologically aggressive features in hepatocellular carcinoma.
    Morinaga S; Nakamura Y; Ishiwa N; Yoshikawa T; Noguchi Y; Yamamoto Y; Rino Y; Imada T; Takanashi Y; Akaike M; Sugimasa Y; Takemiya S
    Oncol Rep; 2004 Dec; 12(6):1189-94. PubMed ID: 15547736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heparanase expression in human colorectal cancer and its relationship to tumor angiogenesis, hematogenous metastasis, and prognosis.
    Sato T; Yamaguchi A; Goi T; Hirono Y; Takeuchi K; Katayama K; Matsukawa S
    J Surg Oncol; 2004 Sep; 87(4):174-81. PubMed ID: 15334632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of a unique gamma-glutamyl transpeptidase messenger RNA species closely related to the development of hepatocellular carcinoma in humans: a new candidate for early diagnosis of hepatocellular carcinoma.
    Tsutsumi M; Sakamuro D; Takada A; Zang SC; Furukawa T; Taniguchi N
    Hepatology; 1996 May; 23(5):1093-7. PubMed ID: 8621139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-time quantification of human telomerase reverse transcriptase mRNA in liver tissues from patients with hepatocellular cancer and chronic viral hepatitis.
    Satra M; Gatselis N; Iliopoulos D; Zacharoulis D; Dalekos GN; Tsezou A
    J Viral Hepat; 2007 Jan; 14(1):41-7. PubMed ID: 17212643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor activator of nuclear factor-kappaB ligand (RANKL) expression in hepatocellular carcinoma with bone metastasis.
    Sasaki A; Ishikawa K; Haraguchi N; Inoue H; Ishio T; Shibata K; Ohta M; Kitano S; Mori M
    Ann Surg Oncol; 2007 Mar; 14(3):1191-9. PubMed ID: 17195907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression and clinical significance of coagulate and fibrolysis factors in tissue and plasma from hepatocellular carcinoma patients].
    Zhou Q; Liang LJ; Peng BG; Zhen YY
    Ai Zheng; 2006 Nov; 25(11):1433-8. PubMed ID: 17094916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative change in albumin messenger RNA levels in patients with hepatocellular carcinoma.
    Gion T; Taketomi A; Shimada M; Shirabe K; Hasegawa H; Takenaka K; Sugimachi K
    Hepatology; 1998 Dec; 28(6):1663-8. PubMed ID: 9828232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of NET-1 gene and protein in hepatocellular carcinoma and related tissues].
    Chen L; Shen AG; Wang GL; Lu P; Li XY
    Ai Zheng; 2006 Mar; 25(3):320-5. PubMed ID: 16536986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparanase messenger RNA expression in epithelial ovarian tumor.
    Kodama J; Shinyo Y; Hashen G; Hongo A; Yoshinouchi M; Hiramatsu Y
    Int J Mol Med; 2003 Dec; 12(6):961-4. PubMed ID: 14612974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.